Author
Share article
The post has been shared by 0
people.
U.S. health policy is entering a new chapter. Robert F. Kennedy Jr. is backing expanded access to peptide-based therapies — a move now drawing strong interest from both the medical and wellness communities.Peptides, including widely used treatments like insulin and GLP-1 drugs for weight management, are already a key part of modern medicine. Now, their potential is expanding — from improving metabolism to supporting faster recovery.Kennedy’s approach reflects a shift toward more flexible and personalized healthcare. Possible regulatory changes could allow licensed compounding pharmacies to play a bigger role, giving patients more options when standard treatments are not enough